Design of diffusion‐controlled drug delivery devices for controlled release of Paclitaxel

Abstract

Controlled drug delivery devices were predicted in a reverse engineering framework for the controlled release of Paclitaxel, an anti-cancer drug, widely used in the treatment of solid tumors. Using quantitative structure-property relationship models for mutual diffusion coefficients of the drug in biocompatible and biodegradable polymers and partition coefficients of the drug between polymers and blood, a framework was developed to predict optimal drug delivery devices for desired dosage regimens.The validation of the predicted mutual diffusion and partition coefficients using experimental data was reported in previous studies. Optimal design parameters along with selection of most appropriate polymers suitable for different dosage regimens, selected based on current clinical practice, were predicted for maximum bioavailability of the drug while maintaining the released drug concentration in blood within the therapeutic range. Reservoir and monolithic type of diffusion-controlled drug delivery devices of different shapes and sizes were predicted with different initial drug loadings and bioavailability for different dosage regimens. The effects of the released Paclitaxel from these devices on the tumor growth were also modeled using a previously reported mathematical pharmacokinetic-pharmacodynamic model. The proposed approach can easily be used to design other diffusion-controlled drug delivery devices. K E Y W O R D Scontrolled drug release, in silico modeling, paclitaxel, QSPR, reverse engineering | 1479 PRAMANIK ANd GARG How to cite this article: Pramanik A, Garg S. Design of diffusion-controlled drug delivery devices for controlled release of Paclitaxel. Chem Biol Drug Des.

Synthesis and Characterization of a Fullerenol Derivative for Potential Biological Applications

“…The nanocarriers' design for pharmaceutical applications one of the main challenges is to overcome several biological barriers as they are generally responsible for the limited delivery of functional cargoes at the target sites. The main consequence is the limited bioavailability of the pharmacological molecules, which is reflected in an increased number of dosages to reach the minimum effective concentration [1,2]. At the cellular scale, some of these barriers include the plasma membrane for the initial internalization and the endosomal one after cellular uptake.…”

Chitosan Nanoparticle-Based System: A New Insight into the Promising Controlled Release System for Lung Cancer Treatment

“…The diffusion-controlled drug release system was divided into monolithic-and reservoirtype, where both were generally initiated by drug permeated through the interior of the polymeric matrix and to the adjacent medium [131]. Interestingly, diffusion may be related to the swelling or erosion of a polymer.…”

Development and Evaluation of Amlodipine-Polymer Nanocomposites Using Response Surface Methodology

“…The drug is held in a core that is covered by a polymer. Therefore, the drug diffuses from the core to the outside polymer [36]. As a result, the bonds between the medication and the polymer start breaking [37].…”